ClinicalTrials.gg
Drug

Deferiprone clinical trials

Also written L1.

studies test it
45
open now
3
in phase 3
11
first study started
2000

How each study uses Deferiprone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Deferiprone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Oct 2011 · FERRIPROX · NDA 021825 (FDA, Drugs@FDA)
European Union
25 Aug 1999 · Ferriprox · EMEA/H/C/000236 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Deferiprone
26
Ferriprox
14
DFP
8
Deferiprone oral solution
4
Deferiprone (L1)
2

Development codes

L1
6

Studies by the year they started

45 studies that test it; most in 2012 (6)

Studies that test Deferiprone, by start year
YearStudies
20001
20022
20041
20051
20061
20071
20082
20093
20111
20126
20134
20146
20154
20165
20183
20191
20221
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
19
Phase 3
11
Phase 4
9
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 23

ApoPharma (18) · University Hospital, Lille (5) · Ain Shams University (3) · Lipomed (2) · Neuroscience Trials Australia (1) · Chiesi Canada Corp (1) · Consorzio per Valutazioni Biologiche e Farmacologiche (1) · Imperial College London (1)

Often tested with

Tested in the same studies.

Deferoxamine (5) · Deferasirox (2) · Moxifloxacin (1) · Diarylheptanoids (1) · Acetylcysteine (1) · Vitamin E (1) · Alpha-Tocopherol (1) · Blood Transfusion (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Deferiprone.

Studies

Open first, then newest update. How each study uses Deferiprone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 45

See all 45 studies that test Deferiprone →

Given beside what is tested · 2 — Deferiprone is usual care or a partner of the new treatment

Codes

What other systems call Deferiprone · ClinicalTrials.gg INT006740

  • MeSH (NLM) D000077543DeferiproneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2BTY8KH53LDEFERIPRONEConfirmed FDA, NLM, Wikidata
  • RxNorm 11645Confirmed FDA, Wikidata
  • Wikidata Q749664deferiproneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C73030DeferiproneOne source FDA
  • DrugBank DB08826One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.